LIFECORE BIOMEDICAL, INC. \DE\ — Director's Dealing 2017

Oct 23, 2017

SEC Form 4/A — Form 4/A

Issuer: LANDEC CORP \CA\ (LNDC)
CIK: 0001005286
Period of Report: 2017-10-19

Reporting Person: SKINNER GREGORY S (VP Finance and Admin & CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-10-20	Common Stock	M	8913	$13	Acquired	247623	Direct
2017-10-20	Common Stock	F	3349	$13	Disposed	244274	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-10-19	Incentive Stock Option (Right to Buy)	$12.65	M	21000	Acquired	2024-10-19	Common Stock (21000)	Direct
2017-10-19	Right to Buy Restricted Stock Unit (RSU)	$	M	7000	Acquired	2020-10-19	Common Stock (7000)	Direct
2017-10-20	Right to Buy Restricted Stock Unit (RSU)	$13	M	8913	Disposed	2017-10-20	Common Stock (8913)	Direct

Footnotes

F1: Restricted Stock Units will vest on the 3rd anniversary of the grant date and will be automatically settled in shares of common stock subject to vesting at a rate of 1 share per unit.

F2: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.